ARENA PHARMACEUTICALS INC (ARNA) Stock Analyst Ratings
NASDAQ:ARNA - Nasdaq - Common Stock
ChartMill assigns a Buy % Consensus number of 69% to ARNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 99.8. This target is -0.19% below the current price.
ARNA was analyzed by 19 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about ARNA.
In the previous month the buy percentage consensus was at a similar level.
ARNA was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-09 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-12-21 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2021-12-14 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2021-12-14 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2021-12-14 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2021-12-14 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2021-12-14 | Citigroup | Downgrade | Buy -> Neutral |
| 2021-12-14 | Jefferies | Downgrade | Buy -> Hold |
| 2021-12-13 | Needham | Downgrade | Buy -> Hold |
| 2021-12-08 | Wells Fargo | Initiate | Overweight |
| 2021-08-10 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-08-06 | Credit Suisse | Maintains | Outperform |
| 2021-05-18 | Goldman Sachs | Initiate | Buy |
| 2021-05-07 | SVB Leerink | Maintains | Outperform |
| 2021-04-27 | Citigroup | Initiate | Buy |
| 2021-04-13 | Credit Suisse | Maintains | Outperform |
| 2021-03-26 | HC Wainwright & Co. | Maintains | Buy |
| 2021-03-03 | Cantor Fitzgerald | Maintains | Overweight |
| 2021-02-24 | SVB Leerink | Maintains | Outperform |